drugset
drugset / Trial / NCT01398852

Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia

NCT01398852 ↗

Phase 3 Terminated 500 enrolled Topcon Medical Systems, Inc.
NaSingle-groupOpen-labelOther

Summary

The purpose of this research study is to evaluate the long tern safety and effectiveness of cross-linking in eyes with keratoconus and ectasia.

Timeline

Start
2010-12
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Riboflavin Other / unclassified — —

Indications

keratoconus